Author

Lounes Djerroudi

Observed names: Djerroudi, Lounes, L. Djerroudi, Lounes Djeroudi

Institutions: Centre National de la Recherche Scientifique, Memorial Sloan Kettering Cancer Center, Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Chimie et Biologie de la Cellule, Institut Curie

Observed institutions: Hôpital Necker-Enfants Malades, Centre National de la Recherche Scientifique, Memorial Sloan Kettering Cancer Center, Inserm, Université Paris Sciences et Lettres, La Ligue Contre le Cancer, Assistance Publique – Hôpitaux de Paris, UniCancer Group, Hôpital Saint-Louis, Chimie et Biologie de la Cellule, Recherche clinique appliquée à l'hématologie, Centre d'Investigation Clinique Biothérapies Necker, Institut Curie

ORCID: 0000-0002-5007-2964

Observed ORCID: 0000-0002-5007-2964

OpenAlex ID: A5079876132

Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

2024 · Hugo Croizer, Rana Mhaidly, et al. · Nature Communications · 164

PDF

Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers

2023 · Toulsie Ramtohul, Lounes Djerroudi, et al. · Radiology · 130

Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

2021 · Matthias Christgen, Gábor Cserni, et al. · Cancers · 96

PDF

Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway

2024 · Monika Licaj, Rana Mhaidly, et al. · Nature Communications · 62

PDF

Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

2021 · Camille Franchet, Lounes Djerroudi, et al. · Annales de Pathologie · 47

Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma

2020 · Jean-Christophe Tille, André F. Vieira, et al. · Modern Pathology · 45

Emerging Role of IL-4–Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma

2018 · Jan Philipp Ramspott, Fériel Bekkat, et al. · Journal of Investigative Dermatology · 39

[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab

2023 · Romain-David Seban, Emilie Arnaud, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 33

PDF

Clinico-pathological factors predicting pathological response in early triple-negative breast cancer

2025 · Clara Helal, Lounes Djerroudi, et al. · npj Breast Cancer · 26

PDF

Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression

2021 · Haifeng Xu, Tonje Lien, et al. · Frontiers in Genetics · 23

PDF

E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma

2024 · Lounes Djerroudi, Amel Bendali, et al. · Modern Pathology · 22

PDF

Malignant phyllodes tumours of the breast: the case for revising WHO’ s ‘full house’ diagnostic criteria

2025 · Puay Hoon Tan, Ian O Ellis, et al. · Histopathology · 20

PDF

Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management

2025 · Emad A. Rakha, Cecily Quinn, et al. · Modern Pathology · 18

Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma

2019 · Marianne Delville, Fabien Touzot, et al. · Molecular Therapy — Methods & Clinical Development · 17

PDF

Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study

2021 · Marion Alhenc-Gelas, Luc Cabel, et al. · Breast Cancer Research · 13

PDF

Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy

2025 · Toulsie Ramtohul, Derek Lollivier, et al. · Radiology · 12

Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas

2021 · Sophie El Zein, Lounes Djeroudi, et al. · Genes Chromosomes and Cancer · 11

Clinical challenges and proposed solutions for patients with invasive lobular breast cancer

2025 · K. Van Baelen, E. Sawyer, et al. · Annals of Oncology · 10

PDF

Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab

2023 · Lounes Djerroudi, Julien Masliah-Planchon, et al. · JCO Precision Oncology · 10

Invasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?

2022 · Lounes Djerroudi, Luc Cabel, et al. · JNCI Journal of the National Cancer Institute · 10

PDF

Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer

2024 · Romain-David Seban, Laurence Champion, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 9

PDF

Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas

2024 · Lounes Djerroudi, Ahmad El Sabeh-Ayoun, et al. · Modern Pathology · 9

Biopathologic Characterization and Grade Assessment of Breast Cancer With 3-D Multiparametric Ultrasound Combining Shear Wave Elastography and Backscatter Tensor Imaging

2024 · Jean-Baptiste Guillaumin, Lounes Djerroudi, et al. · Ultrasound in Medicine & Biology · 6

PDF

Proof of Concept of 3-D Backscatter Tensor Imaging Tomography for Non-invasive Assessment of Human Breast Cancer Collagen Organization

2022 · Jean-Baptiste Guillaumin, Lounes Djerroudi, et al. · Ultrasound in Medicine & Biology · 6

Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?

2025 · Romain-David Seban, Louis Rebaud, et al. · Annals of Nuclear Medicine · 5

PDF

Works count: 85

Citation count: 868

H-index: 14

I10-index: 20